Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PPARs and fibrosis].

Masahiko Kurabayashi1

  • 1Department of Medicine and Biological Science, Gunma University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 15, 2005
PubMed
Summary

Inflammation contributes to fibrosis, particularly in the heart. PPARs may offer a therapeutic strategy by targeting inflammation and reactive oxygen species production linked to Angiotensin II.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted deep sequencing analyses of long QT syndrome in a Japanese population.

PloS one·2022
Same author

Short-Term Exposure to Sulfur Dioxide and Nitrogen Monoxide and Risk of Out-of-Hospital Cardiac Arrest.

Heart, lung & circulation·2022
Same author

Novel CACNA1C R511Q mutation, located in domain Ⅰ-Ⅱ linker, causes non-syndromic type-8 long QT syndrome.

PloS one·2022
Same author

Ketone body and FGF21 coordinately regulate fasting-induced oxidative stress response in the heart.

Scientific reports·2022
Same author

Peripheral Venous Pressure-Assisted Exercise Stress Echocardiography in the Evaluation of Pulmonary Hypertension During Exercise in Patients With Suspected Heart Failure With Preserved Ejection Fraction.

Circulation. Heart failure·2022
Same author

Impact of left atrial enlargement on image quality in coronary computed tomography angiography.

Clinical imaging·2022

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pharmacology

Background:

  • Inflammation is intrinsically linked to fibrotic processes, notably in cardiac remodeling associated with hypertension and ischemia.
  • Angiotensin II (AngII) promotes fibroblast growth and collagen synthesis, key factors in cardiac remodeling.
  • AngII stimulates reactive oxygen species (ROS) production via NADPH oxidase, contributing to tissue injury in various organs.

Purpose of the Study:

  • To explore the role of Angiotensin II in inflammation-driven cardiac fibrosis.
  • To investigate the potential of Peroxisome proliferator-activated receptors (PPARs) as therapeutic targets for cardiac and perivascular fibrosis.

Main Methods:

  • Review of published studies on Angiotensin II, ROS, NADPH oxidase, and PPARs.
  • Analysis of the molecular mechanisms linking AngII, ROS, inflammation, and fibrosis.
  • Evaluation of PPARs' inhibitory effects on NADPH oxidase and NF-kappaB activation.

Main Results:

  • Angiotensin II enhances ROS production, contributing to tissue injury and fibrosis.
  • PPARgamma ligands have been shown to reduce NADPH oxidase activity.
  • PPARs inhibit inflammation by blocking NF-kappaB activation, a redox-sensitive transcription factor.

Conclusions:

  • PPARs represent promising therapeutic targets for mitigating cardiac and perivascular fibrosis.
  • Targeting PPARs may offer a strategy to counteract AngII-induced inflammation and ROS production, thereby reducing fibrotic remodeling.

Related Experiment Videos